Back to BANK OF AMERICA CORP /DE/ BANK OF AMERICA CORP /DE/

ABCLABCL
15 quarters

Position history for BANK OF AMERICA CORP /DE/BANK OF AMERICA CORP /DE/'s holdings in ABCELLERA BIOLOGICS INC

Yes. Bank of America holds 6,141,539 shares of ABCL (Abcellera Biologics), worth $48.2M, as of its Q2 2026 13F filing. It increased the position by 3,141,603 shares (+104.7%) from Q1 2026. Bank of America has held ABCL in every 13F on record since Q4 2022, 15 quarterly filings.

Current Value

$48.2M

Current Shares

6.1M

Total Value Change

+$47.2M

Total Shares Change

+6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
6.1M
+104.7%
$48.2M0.0%$7.85
47
2026-Q1
Increased
3M
+13.9%
$10.5M0.0%$3.71
32
2025-Q4
Increased
2.6M
+8.9%
$9M0.0%$3.45
30
2025-Q3
Increased
2.4M
+977.8%
$12.2M0.0%$4.87
45
2025-Q2
Increased
224,365
+1304.5%
$769,5720.0%$3.61
40
2025-Q1
Decreased
15,975
-6.8%
$35,6250.0%$2.31
0
2024-Q4
Decreased
17,141
-10.2%
$50,2230.0%$2.82
0
2024-Q3
Increased
19,077
+86.3%
$49,6000.0%$2.61
22
2024-Q2
Decreased
10,240
-93.5%
$30,3100.0%$2.96
0
2024-Q1
Decreased
157,083
-8.4%
$711,5860.0%$4.53
0
2023-Q4
Decreased
171,516
-2.8%
$979,3570.0%$5.71
0
2023-Q3
Increased
176,534
+312.8%
$812,0560.0%$4.60
40
2023-Q2
Decreased
42,763
-74.1%
$276,2480.0%$6.58
0
2023-Q1
Increased
165,361
+69.7%
$1.2M0.0%$7.42
38
2022-Q4
First report
97,429
-
$986,9550.0%$10.13
0

Other major holders of ABCL: VIKING GLOBAL INVESTORS LP, BAKER BROS. ADVISORS LP, Capital World Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used